TM
Thomas McNaughton
Chief Financial Officer

Thomas McNaughton insider trades: Biostage (BSTG) stock purchases

Chief Financial Officer, Biostage Last trade Jun 15, 2018 27 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
10
Open-market trades
since 2015
3
Companies
last trade 2018

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Thomas reports to the SEC

Open-market buys and sales

10 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 15, 2018BSTG↑ Buy$11K
May 20, 2016BSTG↑ Buy$8K
Nov 19, 2015HART↑ Buy$17K
Nov 18, 2015HART↑ Buy$16K
Nov 17, 2015HART↑ Buy$20K
Aug 26, 2015HART↑ Buy$9K
Aug 21, 2015HART↑ Buy$66K
Jun 3, 2015HART↑ Buy$30K
May 29, 2015HART↑ Buy$10K
Feb 13, 2015HART↑ Buy$37K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Thomas McNaughton's insider trades

Thomas McNaughton is Chief Financial Officer at Biostage (BSTG). Since Feb 13, 2015, Thomas has reported 10 open-market purchases worth $222K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (13 filings), other transactions (2 filings), option exercises (1 filing), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every BSTG insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.